Explore how Dilip Shanghvi's strategic acquisitions turned Sun Pharma into a $45 billion giant.

The core idea is shifting the focus from defending the rupee (short-term noise) to upgrading India's capital architecture. This systemic change is the "structural force" needed to unlock Nifty 50's potential for 100,000.